Latest Supriya Lifescience stock price
Supriya Lifescience P/E Ratio
SUPRIYA • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
33.11
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
33.11
Current Price
₹736.70
EPS (TTM)
₹23.35
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
53.55
Sector Median
30.38
Sector Rank
#11 of 131
Sector Percentile
8.4%
Key P/E Ratio Insights for Supriya Lifescience
- Stock appears overvalued with PE of 33.11, suggesting caution for new investments
- Trading at discount to sector average PE of 53.55
View the SUPRIYA equity price for detailed stock performance.
Related Pages for Supriya Lifescience
Additional stock information and data for SUPRIYA
Sector P/E Ratio Comparison
Comparing Supriya Lifescience with other companies in Healthcare sector
Sector Average
53.55
Sector Median
30.38
Lowest P/E
1.5
Highest P/E
628.04
Companies
131
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.5 | ₹51 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 3.18 | ₹733 | Low |
| Murae Organisor | MURAE | 3.86 | ₹55 | Low |
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Zenith Drugs | ZENITHDRUG | 9.06 | ₹84 | Low |
| Galaxy Medicare | GML | 9.5 | ₹32 | Low |
| Balaxi Pharmaceuticals | BALAXI | 10.06 | ₹139 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Vasundhara Rasayans | VRL | 11.3 | ₹51 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |